Abstract:Neurodegenerative disorders are straining public health worldwide. During neurodegenerative disease progression, aberrant neuronal network activity, bioenergetic impairment, adaptive neural plasticity impairment, dysregulation of neuronal Ca2+ homeostasis, oxidative stress, and immune inflammation manifest as characteristic pathological changes in the cellular milieu of the brain. There is no drug for the treatment of neurodegenerative disorders, and therefore, strategies/treatments for the prevention or treatment of neurodegenerative disorders are urgently needed. Intermittent fasting (IF) is characterized as an eating pattern that alternates between periods of fasting and eating, requiring fasting durations that vary depending on the specific protocol implemented. During IF, depletion of liver glycogen stores leads to the production of ketone bodies from fatty acids derived from adipocytes, thereby inducing an altered metabolic state accompanied by cellular and molecular adaptive responses within neural networks in the brain. At the cellular level, adaptive responses can promote the generation of synapses and neurons. At the molecular level, IF triggers the activation of associated transcription factors, thereby eliciting the expression of protective proteins. Consequently, this regulatory process governs central and peripheral metabolism, oxidative stress, inflammation, mitochondrial function, autophagy, and the gut microbiota, all of which contribute to the amelioration of neurodegenerative disorders. Emerging evidence suggests that weight regulation significantly contributes to the neuroprotective effects of IF. By alleviating obesity-related factors such as blood-brain barrier dysfunction, neuroinflammation, and β-amyloid accumulation, IF enhances metabolic flexibility and insulin sensitivity, further supporting its potential in mitigating neurodegenerative disorders. The present review summarizes animal and human studies investigating the role and underlying mechanisms of IF in physiology and pathology, with an emphasis on its therapeutic potential. Furthermore, we provide an overview of the cellular and molecular mechanisms involved in regulating brain energy metabolism through IF, highlighting its potential applications in neurodegenerative disorders. Ultimately, our findings offer novel insights into the preventive and therapeutic applications of IF for neurodegenerative disorders.

Energy intake, meal frequency, and health: a neurobiological perspective

Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms

Caloric Restriction, Friend or Foe: Effects on Metabolic Status in Association with the Intestinal Microbiome and Metabolome

Impact of intermittent fasting on health and disease processes

Intermittent fasting: from calories to time restriction

Promoting Health and Longevity through Diet: From Model Organisms to Humans

Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems

Circadian clock and temporal meal pattern

Neurotrophic Effects of Intermittent Fasting, Calorie Restriction and Exercise: A Review and Annotated Bibliography

Effects of Intermittent Fasting on Brain Metabolism

Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans

Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential

Neural Regulation of Feeding Behavior

Nutrition, longevity and disease: From molecular mechanisms to interventions

Intermittent and periodic fasting, longevity and disease

Intermittent fasting and longevity: From animal models to implication for humans

The Effects of Intermittent Fasting on Brain and Cognitive Function

Dietary Interventions For Healthy Aging

Neuroprotective effects of intermittent fasting in the aging brain

The ups and downs of caloric restriction and fasting: from molecular effects to clinical application